Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), a specialty pharmaceutical company, is focusing their efforts on addressing cancer and other unmet medical needs. With headquarters in Irvine, California, the company employs approximately 65 employees that meticulously strive to bring new drugs through clinical development and regulatory approval. Spectrum’s staff is devoted to promoting excellence and aims to make a difference every day. For further information, visit the Company’s web site at www.spectrumpharm.com.
- 16 years ago
QualityStocks
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
Tags Rodman & Renshaw
Related Post
-
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research
Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…
-
ONAR Holding Corp. (ONAR) Is ‘One to Watch’
ONAR is scaling a diversified, AI-driven marketing network addressing multiple high-growth industry verticals. The company…
-
Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare
Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…